These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 554824)

  • 1. [Experimental model for the study of antitumor immunity combined action drugs].
    Fioretti MC; Bonmassar E
    G Ital Chemioter; 1979; 26(1-2):357-62. PubMed ID: 554824
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined effects of antineoplastic agents and anti-lymphoma allograft reactions.
    Riccardi C; Bartocci A; Puccetti P; Spreafico F; Bonmassar E; Goldin A
    Eur J Cancer (1965); 1980 Jan; 16(1):23-33. PubMed ID: 7358077
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity of DTIC (NSC-45388) in animals.
    Venditti JM
    Cancer Treat Rep; 1976 Feb; 60(2):135-40. PubMed ID: 1260771
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-mediated immunogenic changes of virus-induced leukemia in vivo.
    Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A
    Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased life-span in AKR leukemia mice treated with prophylactic chemotherapy.
    Straus MJ; Choi SC; Goldin A
    Cancer Res; 1973 Jul; 33(7):1724-8. PubMed ID: 4721231
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined effects of immunity and antitumor drugs against cancer. I. In vivo studies with cis-diamminedichloroplatinum and cyclophosphamide in mouse models.
    Ricci F; De Filippi R; Riccardi C; Romani L; Giuliani A
    Chemioterapia; 1987 Dec; 6(6):403-9. PubMed ID: 3435922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin A: failure to demonstrate in mice an anti-tumour effect, whether combined with cytotoxic drugs or not.
    Cattan A; Bresson ML
    Bull Cancer; 1986; 73(2):201-6. PubMed ID: 3730637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanisms by which adoptively transferred T cells promote tumor eradication.
    Greenberg PD; Kern DE; Jensen MC; Klarnet JP; Cheever MA
    Prog Clin Biol Res; 1987; 244():127-35. PubMed ID: 2958868
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of chemotherapy on the kinetics of leukemic cell behavior.
    Skipper HE
    Cancer Res; 1965 Oct; 25(9):1544-50. PubMed ID: 5861078
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenicity of L1210 leukemic sublines induced by drugs.
    Nicolin A; Vadlamudi S; Goldin A
    Cancer Res; 1972 Apr; 32(4):653-7. PubMed ID: 5014777
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH; Wallace TL; Richard KA; Tracey DE
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
    Nicolin A; Franco P; Testorelli C; Goldin A
    Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental studies at Southern Research Institute with DTIC (NSC-45388).
    Montgomery JA
    Cancer Treat Rep; 1976 Feb; 60(2):125-34. PubMed ID: 1260770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclophosphamide dose, antileukemic action and immuno-inhibitor effect].
    Mathé G; Schneider M; Schwarzenberg L
    Rev Fr Etud Clin Biol; 1968; 13(7):695-6. PubMed ID: 4882148
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD; Ganu UK; Gokhale SV
    Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 19. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM; Helfman D
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.